ClinConnect ClinConnect Logo
Search / Trial NCT02456974

Antibiotic Dosing in Pediatric Intensive Care

Launched by UNIVERSITY HOSPITAL, GHENT · May 26, 2015

Trial Information

Current as of June 28, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how different antibiotics work in critically ill children, including neonates, infants, and older kids. Specifically, the researchers want to understand how well the body absorbs and processes antibiotics like piperacillin-tazobactam, amoxicillin-clavulanate, vancomycin, and others when given to patients in the pediatric intensive care unit (PICU). The goal is to improve treatment by finding the best dosing for these medications in young patients who are very sick.

To participate in this study, children aged between 1 month and 15 years who are being treated with these antibiotics in the PICU may be eligible. They should have a way for doctors to take blood samples, like an intravenous line, and must not have certain allergies or medical conditions that could complicate the study. Participants can expect to have some blood tests done to help researchers learn how the antibiotics are working in their bodies. This research is important because better understanding antibiotic dosing can lead to more effective treatments for critically ill children.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients admitted to the pediatric intensive care unit
  • patient age/weight : 1,8 kg-15 years
  • patient receiving antibiotic treatment (piperacillin-tazobactam, amoxicillin-clavulanate, vancomycin, teicoplanin, meropenem, ciprofloxacin, amikacin) via intermittent infusion regimen or continuous infusion according to institutional treatment guidelines
  • intra-arterial or intravenous access other than the drug infusion line available for blood sampling (arterial line is preferred)
  • Exclusion Criteria:
  • no catheter in place for blood sampling
  • absence of parental/patient consent
  • known hypersensitivity to beta-lactam antibiotics, glycopeptides, fluoroquinolones, aminoglycosides
  • extracorporeal circuit (haemodialysis, ECMO, peritoneal dialysis )

About University Hospital, Ghent

University Hospital Ghent is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. Located in Ghent, Belgium, the hospital is affiliated with Ghent University, fostering a collaborative environment that integrates cutting-edge medical research with high-quality patient care. With a diverse range of specialized departments and a dedicated team of researchers and clinicians, University Hospital Ghent is at the forefront of developing new therapies and improving treatment protocols, aiming to enhance patient outcomes and contribute to the global medical community.

Locations

Ghent, , Belgium

Patients applied

0 patients applied

Trial Officials

Pieter De Cock

Principal Investigator

University Hospital, Ghent

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials